surf break copy_edited.jpg

'A Strategic Angle': BioscienceLA CEO Talks About Leading Health Care Innovation After The COVID-19

Despite devastating the global economy and harming the health of millions, the COVID-19 pandemic prompted a boost in health care innovation. That’s according to David Whelan, CEO at BioscienceLA, to whom Benzinga spoke regarding opportunities in health and his organization’s role in bolstering innovation.


Recent Posts

See All

Emerging Opportunities: Real-World Evidence

Key takeaways • Real-world evidence (RWE) has the potential to be useful across the entire healthcare ecosystem, including for clinical trials, care provision, determining treatment outcomes, and post

Invitae to Acquire Ciitizens

Invitae (NYSE: NVTA), a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Ciitizen, a patient-centric consumer health tech company. Backed by a16z